|
1
|
International Diabetes Federation (IDF).
IDF Diabetes Atlas (7th). 2017.
|
|
2
|
Balakumar P, Bishnoi HK and Mahadevan N:
Telmisartan in the management of diabetic nephropathy: A
contemporary view. Curr Diabetes Rev. 8:183–190. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hsu YC, Lee PH, Lei CC, Ho C, Shih YH and
Lin CL: Nitric oxide donors rescue diabetic nephropathy through
oxidative-stress-and nitrosative-stress-mediated Wnt signaling
pathways. J Diabetes Investig. 6:24–34. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hiragushi K, Sugimoto H, Shikata K,
Yamashita T, Miyatake N, Shikata Y, Wada J, Kumagai I, Fukushima M
and Makino H: Nitric oxide system is involved in glomerular
hyperfiltration in Japanese normo- and micro-albuminuric patients
with type 2 diabetes. Diabetes Res Clin Pract. 53:149–159. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chiarelli F, Cipollone F, Romano F, Tumini
S, Costantini F, di Ricco L, Pomilio M, Pierdomenico SD, Marini M,
Cuccurullo F and Mezzetti A: Increased circulating nitric oxide in
young patients with type 1 diabetes and persistent
microalbuminuria: Relation to glomerular hyperfiltration. Diabetes.
49:1258–1263. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Knott AB and Bossy-Wetzel E: Impact of
nitric oxide on metabolism in health and age-related disease.
Diabetes Obes Metab. 12 Suppl 2:S126–S133. 2010. View Article : Google Scholar
|
|
7
|
Garsen M, Rops AL, Li J, van Beneden K,
van den Branden C, Berden JH, Rabelink TJ and van der Vlag J:
Endothelial nitric oxide synthase prevents heparanase induction and
the development of proteinuria. PLoS One. 11:e1608942016.
View Article : Google Scholar
|
|
8
|
Nakayama T, Sato W, Kosugi T, Zhang L,
Campbell-Thompson M, Yoshimura A, Croker BP, Johnson RJ and
Nakagawa T: Endothelial injury due to eNOS deficiency accelerates
the progression of chronic renal disease in the mouse. Am J Physiol
Renal Physiol. 296:F317–F327. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu Z, Pan J, Sun C, Zhou J and Li NA:
Clinical effects of perazine ferulate tablets combined with
eucalyptol limonene pinene enteric soft capsules for treatment of
children with IgA nephropathy. Exp Ther Med. 12:169–172. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
You GQ, Fu P, Xie XS, Liu F and Li J:
Effects of piperazine ferulate on TGF-beta1-induced renal
interstitial fibroblast activation. Sichuan Da Xue Xue Bao Yi Xue
Ban. 39:736–739, 762. 2008.(In Chinese). PubMed/NCBI
|
|
11
|
Yin JP, Fu P, Xie XS, Liu F, Liu F and
Zhou L: Effects of piperazine ferulate on connective tissue growth
factor and extracellular matrix in TGF-beta1 induced mesangial
cells. Sichuan Da Xue Xue Bao Yi Xue Ban. 39:732–735. 2008.(In
Chinese). PubMed/NCBI
|
|
12
|
Chakravarthy H, Beli E, Navitskaya S,
O'Reilly S, Wang Q, Kady N, Huang C, Grant MB and Busik JV:
Imbalances in mobilization and activation of pro-inflammatory and
vascular reparative bone marrow-derived cells in diabetic
retinopathy. PLoS One. 11:e1468292016. View Article : Google Scholar
|
|
13
|
Saito T, Sumithran E, Glasgow EF and
Atkins RC: The enhancement of aminonucleoside nephrosis by the
co-administration of protamine. Kidney Int. 32:691–699. 1987.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kanetsuna Y, Takahashi K, Nagata M, Gannon
MA, Breyer MD, Harris RC and Takahashi T: Deficiency of endothelial
nitric-oxide synthase confers susceptibility to diabetic
nephropathy in nephropathy-resistant inbred mice. Am J Pathol.
170:1473–1484. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Prabhakar S, Starnes J, Shi S, Lonis B and
Tran R: Diabetic nephropathy is associated with oxidative stress
and decreased renal nitric oxide production. J Am Soc Nephrol.
18:2945–2952. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kamijo H, Higuchi M and Hora K: Chronic
inhibition of nitric oxide production aggravates diabetic
nephropathy in Otsuka Long-Evans Tokushima Fatty rats. Nephron
Physiol. 104:p12–p22. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Qi H, Casalena G, Shi S, Yu L, Ebefors K,
Sun Y, Zhang W, D'Agati V, Schlondorff D, Haraldsson B, et al:
Glomerular endothelial mitochondrial dysfunction is essential and
characteristic of diabetic kidney disease susceptibility. Diabetes.
66:763–778. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Boels MG, Avramut MC, Koudijs A, Dane MJ,
Lee DH, van der Vlag J, Koster AJ, van Zonneveld AJ, van Faassen E,
Gröne HJ, et al: Atrasentan reduces albuminuria by restoring the
glomerular endothelial glycocalyx barrier in diabetic nephropathy.
Diabetes. 65:2429–2439. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Broekhuizen LN, Lemkes BA, Mooij HL,
Meuwese MC, Verberne H, Holleman F, Schlingemann RO, Nieuwdorp M,
Stroes ES and Vink H: Effect of sulodexide on endothelial
glycocalyx and vascular permeability in patients with type 2
diabetes mellitus. Diabetologia. 53:2646–2655. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gallagher H and Suckling RJ: Diabetic
nephropathy: Where are we on the journey from pathophysiology to
treatment? Diabetes Obes Metab. 18:641–647. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim Y and Park CW: New therapeutic agents
in diabetic nephropathy. Korean J Intern Med. 32:11–25. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hemmelgarn BR, Manns BJ, Lloyd A, James
MT, Klarenbach S, Quinn RR, Wiebe N and Tonelli M; Alberta Kidney
Disease Network, : Relation between kidney function, proteinuria,
and adverse outcomes. JAMA. 303:423–429. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nolin AC, Mulhern RM, Panchenko MV,
Pisarek-Horowitz A, Wang Z, Shirihai O, Borkan SC and Havasi A:
Proteinuria causes dysfunctional autophagy in the proximal tubule.
Am J Physiol Renal Physiol. 311:F1271–F1279. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cheng H, Wang H, Fan X, Paueksakon P and
Harris RC: Improvement of endothelial nitric oxide synthase
activity retards the progression of diabetic nephropathy in db/db
mice. Kidney Int. 82:1176–1183. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ballermann BJ: Glomerular endothelial cell
differentiation. Kidney Int. 67:1668–1671. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lan L, Han Y, Ren W, Jiang J, Wang P and
Hu Z: Advanced glycation endproducts affect the cytoskeletal
structure of rat glomerular endothelial cells via the Ras-related
C3 botulinum toxin substrate 1 signaling pathway. Mol Med Rep.
11:4321–4326. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dellamea BS, Leitão CB, Friedman R and
Canani LH: Nitric oxide system and diabetic nephropathy. Diabetol
Metab Syndr. 6:172014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nakagawa T, Sato W, Glushakova O, Heinig
M, Clarke T, Campbell-Thompson M, Yuzawa Y, Atkinson MA, Johnson RJ
and Croker B: Diabetic endothelial nitric oxide synthase knockout
mice develop advanced diabetic nephropathy. J Am Soc Nephrol.
18:539–550. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Heeringa P, van Goor H, Itoh-Lindstrom Y,
Maeda N, Falk RJ, Assmann KJ, Kallenberg CG and Jennette JC: Lack
of endothelial nitric oxide synthase aggravates murine accelerated
anti-glomerular basement membrane glomerulonephritis. Am J Pathol.
156:879–888. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mohan S, Reddick RL, Musi N, Horn DA, Yan
B, Prihoda TJ, Natarajan M and Abboud-Werner SL: Diabetic eNOS
knockout mice develop distinct macro- and microvascular
complications. Lab Invest. 88:515–528. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Koo JR and Vaziri ND: Effects of diabetes,
insulin and antioxidants on NO synthase abundance and NO
interaction with reactive oxygen species. Kidney Int. 63:195–201.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sönmez MF and Dündar M: Ameliorative
effects of pentoxifylline on NOS induced by diabetes in rat kidney.
Ren Fail. 38:605–613. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Al-Rasheed NM, Al-Rasheed NM, Attia HA,
Al-Amin MA, Al-Ajmi HN, Hasan IH, Mohamad RA and Sinjilawi NA:
Renoprotective effects of fenofibrate via modulation of LKB1/AMPK
mRNA expression and endothelial dysfunction in a rat model of
diabetic nephropathy. Pharmacology. 95:229–239. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sugimoto H, Shikata K, Matsuda M, Kushiro
M, Hayashi Y, Hiragushi K, Wada J and Makino H: Increased
expression of endothelial cell nitric oxide synthase (ecNOS) in
afferent and glomerular endothelial cells is involved in glomerular
hyperfiltration of diabetic nephropathy. Diabetologia.
41:1426–1434. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Komers R and Anderson S: Paradoxes of
nitric oxide in the diabetic kidney. Am J Physiol Renal Physiol.
284:F1121–F1137. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ding Y, Vaziri ND, Coulson R, Kamanna VS
and Roh DD: Effects of simulated hyperglycemia, insulin, and
glucagon on endothelial nitric oxide synthase expression. Am J
Physiol Endocrinol Metab. 279:E11–E17. 2000. View Article : Google Scholar : PubMed/NCBI
|
